The global clinical decision support system market size is projected to reach $3,386.0 million by 2030, advancing at a CAGR of 8.6% during 2021–2030. This can be mainly attributed to the increase in the deployment of big data tools and mobile health and the rise in the adoption of CDSS-enabled EHRs.
In addition, several government organizations are providing support, in the form of funding and initiatives, for the implementation of digital health technologies, including CDSS, which is projected to increase the domain size in the upcoming period. For instance, in 2020, the EU signed a declaration to establish an eHealth common area, allowing free movement of EHRs across Europe.
The integrated CDSS solution bifurcation held the larger CDSS market revenue share, around 70%, in 2021, and it is expected to register a higher CAGR in the forecast period. This is ascribed to the high demand for quality healthcare as well as reliable integrated technical solutions. In addition, the incorporation of cloud-based software with healthcare systems for the smooth functioning and efficient data tracking of patients is burgeoning the category’s revenue.
The in-patient category accounted for the larger market share, of around 75%, in 2021, on account of the increasing number of hospitals and rising number of in-patient admissions. This is itself attributed to the rising prevalence of chronic diseases, which require appropriate treatment. This increases the demand for CDSS in the in-patient settings. Moreover, players operating in the market are actively involved in the development of innovative CDSSs for in-patient settings, which also plays a pivotal role in the growth in the adoption of such solutions among in-patient settings.
North America accounted for the highest value, of around $800 million, in 2021, due to the wide acceptance of advanced technologies by healthcare providers and the presence of prominent players in the region. In addition, the U.S. holds the major revenue share, of approximately 90%, in the region, propelled by the increasing focus on delivering quality health services in the country.
Europe held the second-largest market share in the global CDSS market during the historical period. Moreover, the region is further expected to hold around 30% share in 2030. The revenue growth in the European region is attributed to the increasing demand for mHealth technologies, rising prevalence of chronic diseases, and surging geriatric population. Among the European countries, Germany is projected to hold around 25% share in 2030.
The major players operating in the global CDSS market are McKesson Corporation, Cerner Corporation, Siemens Healthineers GmbH, Allscripts Healthcare LLC, athenahealth Inc., NextGen Healthcare Inc., and Koninklijke Philips N.V.